← Steven E. Nissen

Papers by Steven E. Nissen

Page 4 · newest first

151. The National Institute for Health and Care Excellence update for stable chest pain: poorly reasoned and risky for patientsHeart · 2017
152. Conflicts of Interest and Professional Medical AssociationsJAMA · 2017
153. Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year OutcomesNew England Journal of Medicine · 2017
154. Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT studyCardiovascular Diagnosis and Therapy · 2017
155. Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: T he EXAMINE trialDiabetes Obesity and Metabolism · 2017
156. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for ArthritisNew England Journal of Medicine · 2016
157. Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor AlogliptinHypertension · 2016
158. Sex Differences in Nonculprit Coronary Plaque Microstructures on Frequency-Domain Optical Coherence Tomography in Acute Coronary Syndromes and Stable Coronary Artery DiseaseCirculation Cardiovascular Imaging · 2016
159. Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesNew England Journal of Medicine · 2016
160. Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE TrialDiabetes Care · 2016
161. Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk FactorsJAMA · 2016
162. Two‐year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapyObesity · 2015
163. Safety of Oral Dofetilide for Rhythm Control of Atrial Fibrillation and Atrial FlutterCirculation Arrhythmia and Electrophysiology · 2015
164. Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery diseaseCardiovascular Endocrinology · 2015
165. Effect of Bariatric Surgery Versus Intensive Medical Management on Diabetic Ophthalmic OutcomesDiabetes Care · 2015
166. Adults with long‐duration type 2 diabetes have blunted glycemic and β‐Cell function improvements after bariatric surgeryObesity · 2015
167. Spotty calcification and plaque vulnerability in vivo: frequency-domain optical coherence tomography analysis.2014
168. HCAHPS Survey Results: Impact of Severity of Illness on Hospitals' Performance on HCAHPS Survey ResultsJournal of Patient Experience · 2014
169. Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non‐remission status after bariatric surgeryDiabetes Obesity and Metabolism · 2014
170. Progression of coronary atherosclerosis in stable patients with ultrasonic features of high-risk plaquesEuropean Heart Journal - Cardiovascular Imaging · 2014
171. Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year OutcomesNew England Journal of Medicine · 2014
172. Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trialAmerican Heart Journal · 2013
173. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 DiabetesNew England Journal of Medicine · 2013
174. Progression of coronary atherosclerosis in African-American patients.2013
175. Metabolic Effects of Bariatric Surgery in Patients With Moderate Obesity and Type 2 DiabetesDiabetes Care · 2013
176. Bariatric Surgery Versus Intensive Medical Therapy in Obese Patients With DiabetesSurvey of Anesthesiology · 2013
177. Cardiovascular Effects of Diabetes Drugs: Emerging From the Dark AgesAnnals of Internal Medicine · 2012
178. Cox-2 inhibitors and cardiovascular disease: considerable heat, but not much lightEuropean Heart Journal · 2012
179. Effect of Two Intensive Statin Regimens on Progression of Coronary DiseaseSurvey of Anesthesiology · 2012
180. Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with DiabetesNew England Journal of Medicine · 2012
181. Pharmacogenomics and ClopidogrelJAMA · 2011
182. Risk Prediction with Serial Myeloperoxidase Monitoring in Patients with Acute Chest PainClinical Chemistry · 2011
183. Effect of rimonabant on carotid intima–media thickness (CIMT) progression in patients with abdominal obesity and metabolic syndrome: the AUDITOR TrialHeart · 2011
184. Left Main Trunk Coronary Artery Dissection as a Consequence of Inaccurate Coronary Computed Tomographic AngiographyArchives of Internal Medicine · 2010
185. Cardiogenic shock in the setting of severe aortic stenosis: role of intra-aortic balloon pump supportHeart · 2010
186. Rosiglitazone RevisitedArchives of Internal Medicine · 2010
187. The rise and fall of rosiglitazoneEuropean Heart Journal · 2010
188. Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional AnalysisPLoS Medicine · 2009
189. Professional Medical Associations and Their Relationships With IndustryJAMA · 2009
190. Preliminary Observations From Preliminary Trial ResultsCirculation Cardiovascular Quality and Outcomes · 2008
191. Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 DiabetesJAMA · 2008
192. Do the extent and direction of arterial remodelling predict subsequent progression of coronary atherosclerosis? A serial intravascular ultrasound studyHeart · 2007
193. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.2007
194. Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular CausesNew England Journal of Medicine · 2007
195. ADAPT: The Wrong Way to Stop a Clinical TrialPLoS Clinical Trials · 2006
196. Identification of the Metabolic Syndrome and Imaging of Subclinical Coronary Artery DiseaseThe Journal of Cardiovascular Nursing · 2006
197. Determinants of Arterial Wall Remodeling During Lipid-Lowering TherapyCirculation · 2006
198. ADHD Drugs and Cardiovascular RiskNew England Journal of Medicine · 2006
199. Effect of Muraglitazar on Death and Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes MellitusJAMA · 2005
200. Surrogate markers for atherosclerotic diseaseCurrent Opinion in Lipidology · 2005